ReviewTranslational neurodegeneration2021
Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in China.
Open access · goldAbstract readReviewConsensus Statement
In one paragraph
Review in Translational neurodegeneration, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 43 citations in OpenAlex.
- Clinical spectrum and treatment responses in.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Article
- Multidisciplinary perinatal management of paroxysmal kinesigenic dyskinesia in pregnancy: a case report and a proposed structured pathway.Frontiers in medicine · 2026Article
- High Genetic Diagnostic Yield for Patients with Rare Movement Disorders at a Single-Center Neurogenetics Clinic.Movement disorders clinical practice · 2025Article
- Paroxysmal Dyskinesias in Paediatric Age: A Systematic Review.Journal of clinical medicine · 2025Review
- Paroxysmal Dyskinesias Secondary to HHV-6A Encephalitis: The First Case Report and Literature Review.Annals of clinical and translational neurology · 2025Review
- Transient Dysarthria and Hemiparesis in an Adolescent.European journal of case reports in internal medicine · 2025Article
- Evaluating the Performance ofCombinatorial chemistry & high throughput screening · 2025Article
- Gray matter structural alterations of cortico-striato-thalamo-cortical loop in familial Paroxysmal Kinesigenic Dyskinesia.Heliyon · 2024Article
- Dengue and Typhoid: A Duet of Choreoathetosis.Cureus · 2024Article
- A new genetic diagnosis strategy for paroxysmal kinesigenic dyskinesia: Targeted high-throughput detection of PRRT2 gene c.649 locus.Molecular genetics & genomic medicine · 2024Article
- Identification of a de novo CACNA1B variant and a start-loss ADRA2B variant in paroxysmal kinesigenic dyskinesia.Heliyon · 2024Article
- An Electroencephalography Profile of Paroxysmal Kinesigenic Dyskinesia.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Article
- Functional seizures and their mimics: a retrospective service review of cases from a tertiary video telemetry database.BMJ neurology open · 2024Article
- TMEM151A variants associated with paroxysmal kinesigenic dyskinesia.Human genetics · 2023Article
- Genetic Movement Disorders Commonly Seen in Asians.Movement disorders clinical practice · 2023Review
- Lamotrigine as an alternative treatment for paroxysmal kinesigenic dyskinesia.Annals of the Child Neurology Society · 2023Article
- Evaluation of iron deposition in the motor CSTC loop of a Chinese family with paroxysmal kinesigenic dyskinesia using quantitative susceptibility mapping.Frontiers in neurology · 2023Article
- Altered brain state during episodic dystonia in tottering mice decouples primary motor cortex from limb kinematics.Dystonia (Lausanne, Switzerland) · 2023Article
- Elderly-Onset Paroxysmal Kinesigenic Dyskinesia: A Case Report.Neurology and therapy · 2022Article
- Clinical and genetic analyses of 150 patients with paroxysmal kinesigenic dyskinesia.Journal of neurology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
52 authors at 20 institutions in 2 countries.
Li Cao *Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. caoli2000@yeah.net.ORCID 0000-0003-1742-9877
Xiaojun Huang *Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ning WangDepartment of Neurology and Institute of Neurology, The First Affiliated Hospital, Fujian Medical University; Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China.
Zhiying WuDepartment of Neurology and Research Center of Neurology, The Second Affiliated Hospital; Key Laboratory of Medical Neurobiology of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou, China.
Cheng ZhangDepartment of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases; National Key Clinical Department and Key Discipline of Neurology, Guangzhou, China.
Weihong GuDepartment of Neurology, China-Japan Friendship Hospital, Movement Disorder and Neurogenetics Research Center, Beijing, China.
Shuyan CongDepartment of Neurology, Shengjing Hospital of China Medical University, Shenyang, China.
Jianhua MaDepartment of Neurology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Ling WeiDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Collaborative Innovation Center for Neuropsychiatric Disorders and Mental Health, Anhui Medical University; Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei, China.
Yanchun DengDepartment of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Qi FangDepartment of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Qi NiuDepartment of Neurology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jin WangDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zhaoxia WangDepartment of Neurology, Peking University First Hospital, Beijing, China.
You YinDepartment of Neurology, Changzheng Hospital, the PLA Naval Medical University, Shanghai, China.
Jinyong TianDepartment of Neurology and Department of Emergency, Guizhou Provincial People's Hospital, Guiyang, China.
Shufen TianDepartment of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Hongyan BiDepartment of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Hong JiangDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Xiaorong LiuInstitute of Neuroscience and The Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.
Yang LüDepartment of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Meizhen SunDepartment of Neurology, the First Hospital of Shanxi Medical University, Taiyuan, China.
Jianjun WuDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Erhe XuDepartment of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, China.
Tao ChenDepartment of Neurology, Hainan General Hospital, Haikou, China.
Tao ChenDepartment of Neurology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Xu ChenDepartment of Neurology, Shanghai Eighth People's Hospital Affiliated to Jiang Su University, Shanghai, China.
Wei LiDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases; Center of Stroke, Beijing Institute for Brain Disorders; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China.
Shujian LiDepartment of Neurology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.
Qinghua LiDepartment of Neurology, Affiliated Hospital of Guilin Medical University, Guilin Medical University; Guangxi Key Laboratory of Brain and Cognitive Neuroscience, Guilin Medical University, Guangxi Clinical Research Center for Neurological Diseases, Affiliated Hospital of Guilin Medical University, Guilin Medical University; Guangxi Key Laboratory of Brain and Cognitive Neuroscience, Guilin Medical University, Guilin, China.
Xiaonan SongDepartment of Neurology and Neuroscience Center, First Hospital of Jilin University, Changchun, China.
Ying TangDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Ping YangDepartment of Neurology, and Neuroscience Center, General Hospital of Ningxia Medical University, Key Laboratory of Craniocerebral Diseases of Ningxia Hui Autonomous Region, Yinchuan, China.
Yun YangDepartment of Neurology, Jiangxi Provincial People's Hospital Affiliated with Nanchang University, Nanchang, China.
Min ZhangDepartment of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiong ZhangDepartment of Geriatrics and Neurology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.
Yuhu ZhangDepartment of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Ruxu ZhangDepartment of Neurology, The Third Xiangya Hospital, Central South University, Changsha, China.
Yi OuyangDepartment of Neurology, First Affiliated Hospital, China Medical University, Shenyang, China.
Jintai YuDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Quanzhong HuDepartment of Neurology, Qinghai Provincial People's Hospital, Qinghai, China.
Qing KeDepartment of Neurology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yuanrong YaoDepartment of Neurology, Guizhou Provincial People's Hospital, Medical School of Guizhou University, Guiyang, China.
Zhe ZhaoDepartment of Neurology, the Third Hospital of Hebei Medical University, Shijiazhuang, China.
Xiuhe ZhaoDepartment of Neurology, Qilu Hospital, Shandong University, Jinan, China.
Guohua ZhaoDepartment of Neurology, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, China.
Furu LiangDepartment of Neurology, Baotou Central Hospital, Baotou, China.
Nan ChengInstitute of Neurology, Hospital Affiliated with Anhui University of TCM, Hefei, China.
Jianhong HanDepartment of Neurology, Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Rong PengDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, China.
Shengdi ChenDepartment of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. chensd@rjh.com.cn.
Beisha TangDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China. bstang7398@163.com.
Capital Medical University · CNCentral South University · CNKunming Medical University · CNShanghai Jiao Tong University · CNChina Medical University · CNFudan University · CNAnhui Medical University · CNAnhui University · CNBaotou Central Hospital · CNBeihai People's Hospital · CNChina-Japan Friendship Hospital · CNFirst Affiliated Hospital Zhejiang University · CNFujian Medical University · CNGuangdong Academy of Medical Sciences · CNGuangxi Medical University · CNGuilin Medical University · CNGuiyang Medical University · CNGuizhou Provincial People's Hospital · CNGuizhou University · CNHarbin Medical University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paroxysmal dyskinesias are a group of neurological diseases characterized by intermittent episodes of involuntary movements with different causes. Paroxysmal kinesigenic dyskinesia (PKD) is the most common type of paroxysmal dyskinesia and can be divided into primary and secondary types based on the etiology. Clinically, PKD is characterized by recurrent and transient attacks of involuntary movements precipitated by a sudden voluntary action. The major cause of primary PKD is genetic abnormalities, and the inheritance pattern of PKD is mainly autosomal-dominant with incomplete penetrance. The proline-rich transmembrane protein 2 (PRRT2) was the first identified causative gene of PKD, accounting for the majority of PKD cases worldwide. An increasing number of studies has revealed the clinical and genetic characteristics, as well as the underlying mechanisms of PKD. By seeking the views of domestic experts, we propose an expert consensus regarding the diagnosis and treatment of PKD to help establish standardized clinical evaluation and therapies for PKD. In this consensus, we review the clinical manifestations, etiology, clinical diagnostic criteria and therapeutic recommendations for PKD, and results of genetic analyses in PKD patients performed in domestic hospitals.
Indexed as
ChinaChoreaConsensusDystoniaHumansMembrane ProteinsNerve Tissue ProteinsMembrane ProteinsNerve Tissue ProteinsPRRT2 protein, humanChinaDiagnosis and treatmentExpert consensusParoxysmal kinesigenic dyskinesia
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.